To view this email as a web page, click here.

Female Oncologists More Likely to Skip Conferences Due to Family Obligations

A survey of oncologists found child care is a significant concern of women in the field and can greatly impact their conference attendance compared to their male counterparts.

Dr. Fergus Couch on New Genes Implicated in Triple-Negative Breast Cancer Risk

Cancer Network spoke with Fergus Couch, PhD, professor and researcher at the Mayo Clinic in Rochester, Minnesota, about new genes implicated in triple-negative breast cancer risk.

IN CASE YOU MISSED IT

Cell of Origin, MYC/BCL2 Status Did Not Predict Outcomes in Early-Stage DLBCL

Cell of origin and dual expressor/double-hit status may not confer prognosis as originally suspected.

One FDA-approved test analyzes 324 cancer-relevant genes

FoundationOne®CDx analyzes all recommended genomic biomarkers for solid tumors and provides direct paths to therapy for companion diagnostic indications. This one test can help guide therapy selection and clinical trial options for more patients.

Read more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.